Rekombinanter SARS-CoV-2 Spike Antikörper (B.1.351 – beta)

Produktnummer ABIN7515621

Produktdetails anti-SARS-CoV-2 Spike Antikörper

Target: SARS-CoV-2 Spike

Antikörpertyp: Recombinant Antibody

Bindungsspezifität: B.1.351 – beta

Reaktivität: SARS Coronavirus-2 (SARS-CoV-2), SARS CoV-2 Beta

Wirt: Human

Klonalität: Monoklonal

Konjugat: Dieser SARS-CoV-2 Spike Antikörper ist unkonjugiert

Applikation: ELISA, Neutralization (Neut)

Verwendungszweck: Recombinant human monoclonal antibody raised against SARS-CoV-2 Beta Variant S.

Spezifität: Reacts with RBD domain of spike protein of SARS-CoV-2, including South Africa variant (B.1.351) and UK variant (B.1.1.7).

Kreuzreaktivität: SARS Coronavirus-2 (SARS-CoV-2)

Immunogen: Recombinant protein corresponding to SARS-CoV-2 Variant B.1.351 S.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: ELISA,Neutralization Assay,The optimal working dilution should be determined by the end user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In PBS (40 % glycerol).

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C is stable for 6 months from the date of shipment. For long term storage, store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Details zu SARS-CoV-2 Spike

Target: SARS-CoV-2 Spike

Abstract: SARS-CoV-2 Spike Produkte

Synonyme: E2 antikoerper, E2 glycoprotein precursor antikoerper, Surface Glycoprotein antikoerper, S antikoerper

Substanzklasse: Viral Protein